Tag Archives: Accelerating Osteoarthritis Clinical Trials

2017 Osteoarthritis Patient-Focused Drug Development Meeting

Highlights from 2017 Osteoarthritis Patient-Focused Drug Development Meeting

Close to 200 patients, FDA staff, industry leaders, members of the media and academic personnel listened or participated in the groundbreaking Osteoarthritis Patient-Focused Drug Development meeting on March 8. The meeting was a forum for OA patients to share their experiences with the disease and talk about the signs and symptoms that matter most to them.
Continue reading Highlights from 2017 Osteoarthritis Patient-Focused Drug Development Meeting